General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Sangamo Therapeutics (NASDAQ:SGMO) Shares Cross Above 200-Day Moving Average of $0.64 | news.google.com • |
Armistice Capital LLC Has $5.04 Million Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) | news.google.com • |
Ratios Revealed: Decoding Sangamo Therapeutics Inc (SGMO)’s Financial Health | news.google.com • |
3 Penny Stocks To Buy With Just $750 | 247wallst.com • |
What is the investor’s view on Sangamo Therapeutics Inc (SGMO)? | news.google.com • |
A Tale of Resilience: Sangamo Therapeutics Inc Amid Stock Market Turbulence | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-06 | 2024-09 | -0.07 | N/A | N/A | N/A |
2024-08-06 | 2024-06 | -0.16 | -0.17 | -0.01 | -6.25% |
2024-05-09 | 2024-03 | -0.22 | -0.27 | -0.05 | -22.73% |
2024-03-13 | 2023-12 | -0.25 | -0.34 | -0.09 | -36.00% |
2023-11-01 | 2023-09 | -0.33 | -0.34 | -0.01 | -3.03% |
2023-08-08 | 2023-06 | -0.35 | -0.37 | -0.02 | -5.71% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-14 | Truist Securities | Upgrade | Buy | Buy |
2023-08-13 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-10 | Wedbush | Upgrade | Outperform | Outperform |
2023-08-09 | Wells Fargo | Upgrade | Overweight | Overweight |
2023-08-08 | Barclays | Upgrade | Overweight | Overweight |
2023-08-08 | RBC Capital | Upgrade | Outperform | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-06-03 | BEERS COURTNEY | Director | 57.65K | Stock Award(Grant) |
2024-06-03 | CAREY ROBERT F. | Director | 74.60K | Stock Award(Grant) |
2024-01-21 | DURAIBABU PRATHYUSHA | Chief Financial Officer | 843.51K | Stock Award(Grant) |
2024-06-03 | HILLAN KENNETH J. | Director | 74.60K | Stock Award(Grant) |
2024-06-03 | HORN MARGARET A | Director | 57.65K | Stock Award(Grant) |
2024-01-21 | MACRAE SANDY | Chief Executive Officer | 2.59M | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Wasatch Advisors LP | 17.05M | 22.17M | 9.63% |
2023-06-29 | Blackrock Inc. | 15.89M | 20.66M | 8.97% |
2023-06-29 | Vanguard Group Inc | 12.40M | 16.12M | 7.00% |
2023-06-29 | Rokos Capital Management, LLP | 6.47M | 8.42M | 3.66% |
2023-06-29 | Citadel Advisors Llc | 4.50M | 5.84M | 2.54% |
2023-06-29 | Credit Suisse Ag/ | 3.70M | 4.81M | 2.09% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Wasatch Ultra Growth Fund | 6.48M | 8.42M | 3.66% |
2023-06-29 | Wasatch Small Cap Growth Fund | 4.44M | 5.77M | 2.51% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 4.16M | 5.41M | 2.35% |
2023-08-30 | iShares Russell 2000 ETF | 3.33M | 3.22M | 1.88% |
2023-06-29 | Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 2.03M | 2.64M | 1.14% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.88M | 2.44M | 1.06% |
I get the challenge and approach these guys face/are taking coming from both academia translational/clinical trials background and a SGmO investor myself (20+ yrs background). In many ways, they are speaking the language of scientists & clinicians. The reality is, this technology is well grounded and they’ve developed a solid platform that will be the gold standard in this industry soon and years to come. They aspire to meticulously fine tune it even more, tho it comes across as R&D without deliverables. From clinical trial design, publications, abstracts, prior announcements n today’s RND talk, I respect the focus on making sure this works in patients (which it does despite the downplay of recent ASH data - seriously AE from DSMO is unrelated) for long term viability and value. Reading between the lines this company
Their Pfizer/Sanofi alliances are smart and translates to immediate & long term sustainable revenue. And makes a very appetizing gem for potential M&A (wink).
This will be at $18-24 in a year. It’s basically a question of when folks will jump in and how much they wanna profit.